Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 33237646!ä!33237646 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Rev+Med+Suisse 2020 ; 16 (716): 2284-2286 Nephropedia Template TP {{tp|p=33237646|t=2020. Traitement des patients souffrant de Covid-19 aux soins intensifs : l'experience neuchateloise |pdf=|usr=}}{{33237646}} gab.com Text Traitement des patients souffrant de Covid-19 aux soins intensifs : l'experience neuchateloise JO: Rev Med Suisse http://www.kidney.de/pget.php?&tw=1&pmid=33237646 #FOAvip SARS-CoV-2 appeared in Switzerland in February 2020 and reached Neuchatel in March. During 2 months, 43 patients were admitted in the intensive care unit. 55% of ICU admitted patients received mechanical ventilation, 66% of which in prone position. All patients were treated with hydroxychloroquine. The majority of patients received antiretrovirals. One patient was treated with remdesivir. Near half the patients were treated with tocilizumab. One patient received a convalescent plasma obtained from patients who had recovered from COVID-19. The mortality rate was 17%. These results are in line with those from university intensive care units in Switzerland. Twit Text FOAVip Traitement des patients souffrant de Covid-19 aux soins intensifs : l'experience neuchateloise ????Rev Med Suisse http://www.kidney.de/pget.php?&tw=1&pmid=33237646 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33237646 #FOAvip English Wikipedia <ref>{{Cite pmid|33237646}}</ref> Traitement des patients souffrant de Covid-19 aux soins intensifs : l'experience neuchateloise #MMPMID33237646 Haller ML; Brunner ME; Zender HO Rev Med Suisse 2020[Nov]; 16 (716): 2284-2286 PMID33237646show ga SARS-CoV-2 appeared in Switzerland in February 2020 and reached Neuchatel in March. During 2 months, 43 patients were admitted in the intensive care unit. 55% of ICU admitted patients received mechanical ventilation, 66% of which in prone position. All patients were treated with hydroxychloroquine. The majority of patients received antiretrovirals. One patient was treated with remdesivir. Near half the patients were treated with tocilizumab. One patient received a convalescent plasma obtained from patients who had recovered from COVID-19. The mortality rate was 17%. These results are in line with those from university intensive care units in Switzerland. |*Intensive Care Units[MESH] |Betacoronavirus/drug effects[MESH] |COVID-19[MESH] |COVID-19 Serotherapy[MESH] |Coronavirus Infections/epidemiology/*therapy/virology[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Pandemics[MESH] |Pneumonia, Viral/epidemiology/*therapy/virology[MESH] |SARS-CoV-2[MESH]Traitement des patients souffrant de Covid-19 aux soins intensifs : l'(epmc).pdf DeepDyve Pubget Overpricing